Caroline Junqueira

Instituto René Rachou, Fundação Oswaldo Cruz

Affiliated withFundação Oswaldo Cruz Fundação Oswaldo Cruz

Research Area

Biography

Caroline Junqueira has not added Biography.
If you are Caroline Junqueira and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2022

Other Publications

Article	Year
The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease. Expert reviews in molecular medicine\| PubMed ID: 20840799	2010
Trypanosoma cruzi as an effective cancer antigen delivery vector. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 22114198	2011
Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccine. PloS one\| PubMed ID: 22567144	2012
Identification and functional analysis of Trypanosoma cruzi genes that encode proteins of the glycosylphosphatidylinositol biosynthetic pathway. PLoS neglected tropical diseases\| PubMed ID: 23951384	2013
Blockade of CTLA-4 promotes the development of effector CD8+ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1. Cancer immunology, immunotherapy : CII\| PubMed ID: 25403749	2015
Induction of Inhibitory Receptors on T Cells During Plasmodium vivax Malaria Impairs Cytokine Production. The Journal of infectious diseases\| PubMed ID: 26019284	2015
Virus-like Particle Display of the α-Gal Carbohydrate for Vaccination against Infection. ACS central science\| PubMed ID: 28979944	2017
Down Modulation of Host Immune Response by Amino Acid Repeats Present in a Ribosomal Antigen. Frontiers in microbiology\| PubMed ID: 29176965	2017
Comparative transcriptome profiling of virulent and non-virulent Trypanosoma cruzi underlines the role of surface proteins during infection. PLoS pathogens\| PubMed ID: 29240831	2017
New Vaccine Formulations Containing a Modified Version of the Amastigote 2 Antigen and the Non-Virulent CL-14 Strain Are Highly Antigenic and Protective against Challenge. Frontiers in immunology\| PubMed ID: 29599776	2018
Cytotoxic CD8 T cells recognize and kill Plasmodium vivax-infected reticulocytes. Nature medicine\| PubMed ID: 30038217	2018
The immunology of Plasmodium vivax malaria. Immunological reviews\| PubMed ID: 31642531	2020
Decidual NK Cells Transfer Granulysin to Selectively Kill Bacteria in Trophoblasts. Cell\| PubMed ID: 32822574	2020
Contributions of IFN-γ and granulysin to the clearance of Plasmodium yoelii blood stage. PLoS pathogens\| PubMed ID: 32913355	2020
Caspase-8 mediates inflammation and disease in rodent malaria. Nature communications\| PubMed ID: 32929083	2020
Author Correction: Caspase-8 mediates inflammation and disease in rodent malaria. Nature communications\| PubMed ID: 33144583	2020
γδ T cells suppress Plasmodium falciparum blood-stage infection by direct killing and phagocytosis. Nature immunology\| PubMed ID: 33432229	2021
Improved Performance of ELISA and Immunochromatographic Tests Using a New Chimeric A2-Based Protein for Human Visceral Leishmaniasis Diagnosis. Journal of immunology research\| PubMed ID: 34007852	2021
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release. Research square\| PubMed ID: 34401873	2021
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature\| PubMed ID: 35385861	2022
Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature\| PubMed ID: 35483404	2022